Scientists supercharge Patients' own cells to fight deadly skin cancer
NCT ID NCT01701674
Summary
This small pilot study tested whether combining two different immune-boosting treatments could help control advanced melanoma. Researchers collected cancer-fighting immune cells from patients' tumors, grew them in a lab, and then gave them back along with a drug called ipilimumab. The main goals were to see if this combination was safe and practical to deliver, and to look for early signs that it might help shrink tumors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, 33612, United States
Conditions
Explore the condition pages connected to this study.